β2 agonist for the treatment of acute lung injury: A systematic review and meta-analysis

Respiratory Care

Volumn 59, Issue 2, 2014, Pages 288-296

  Singh, Balwinder ^a   Tiwari, Akhilesh Kumar ^c   Singh, Kuljit ^d   Singh, Shannon K ^b   Ahmed, Adil ^a   Erwin, Patricia J ^a   Franco, Pablo Moreno ^b,e  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d QUEEN ELIZABETH HOSPITAL   (Australia)

^e MAYO CLINIC   (United States)

Author keywords

2 agonist; Acute lung injury; Acute respiratory distress syndrome; ALI; ARDS; Mortality; Outcomes; Ventilator free days

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO; SALBUTAMOL;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; HEART ARRHYTHMIA; HEART RATE; HUMAN; META ANALYSIS; MORBIDITY; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL; SYSTEMATIC REVIEW; TACHYCARDIA; VENTILATOR;

ACUTE LUNG INJURY; ACUTE RESPIRATORY DISTRESS SYNDROME; ALI; ARDS; MORTALITY; OUTCOMES; VENTILATOR-FREE DAYS; Β2 AGONIST;

ACUTE LUNG INJURY; ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 84893327701     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02571     Document Type: Review

References (46)

1. Perina DG. Noncardiogenic pulmonary edema. Emerg Med Clin North Am 2003;21(2):385-393.
2. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002;346(21):1631-1636.
3. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002; 82(3):569-600.
4. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163(6):1376-1383.
5. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004;32(7):1470-1476.
6. Lee JW. beta2 adrenergic agonists in acute lung injury? The heart of the matter. Crit Care 2009;13(6):1011.
7. Manocha S, Gordon AC, Salehifar E, Groshaus H, Walley KR, Russell JA. Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury. Crit Care 2006;10(1):R12.
8. Bassford CR, Thickett DR, Perkins GD. The rise and fall of betaagonists in the treatment of ARDS. Crit Care 2012;16(2):208.
9. Perkins GD, McAuley DF, Richter A, Thickett DR, Gao F. Benchto-bedside review: beta2-Agonists and the acute respiratory distress syndrome. Crit Care 2004;8(1):25-32.
10. Papazian L. Con: beta2-adrenergic agonists in ALI/ARDS: not recommended or potentially harmful? Am J Respir Crit Care Med 2011; 184(5):504-506.
11. Perkins GD, McAuley DF. Pro: Beta-agonists in acute lung injury: the end of the story? Am J Respir Crit Care Med 2011;184(5):503-504.
12. Pesenti A, Pelosi P, Rossi N, Aprigliano M, Brazzi L, Fumagalli R. Respiratory mechanics and bronchodilator responsiveness in patients with the adult respiratory distress syndrome. Crit Care Med 1993; 21(1):78-83.
13. Morina P, Herrera M, Venegas J, Mora D, Rodriguez M, Pino E. Effects of nebulized salbutamol on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med 1997;23(1):58-64.
14. O'Kane CM, McKeown SW, Perkins GD, Bassford CR, Gao F, Thickett DR, et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med 2009;37(7):2242-2249.
15. Perkins GD, Nathani N, McAuley DF, Gao F, Thickett DR. In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury. Thorax 2007;62(1):36-42.
16. Gao Smith F, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, et al. Effect of intravenous beta2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012;379(9812):229-235.
17. Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, et al. Randomized, Placebo-controlled Clinical Trial of an Aerosolized beta(2)-Agonist for Treatment of Acute Lung Injury Am J Respir Crit Care Med 2011;184(5):561-568.
18. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173(3):281-287.
19. Singh B, Erwin PJ, Moreno-Franco P. Beta-2-agonist in the treatment of acute lung injury: a meta-analysis (abstract). Crit Care Med 2012;40(12S):100-101.
20. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
21. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-824.
22. Schoenfeld DA, Bernard GR. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002;30(8):1772-1777.
23. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299(6):646-655.
24. Cohen J. A Coefficient of agreement for nominal scales educational and psychological measurement. Educ Psychol Meas 1960;20(April): 37-46.
25. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0, updated March 2011. The Cochrane Collaboration; 2011. http://handbook.cochrane.org. Accessed November 27, 2013.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560.
27. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21(11):1539-1558.
28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-188.
29. The Nordic Cochrane Centre; The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Cochrane Collaboration; 2011.
30. Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Amaha K. Beneficial effect of atrial natriuretic peptide on pulmonary gas exchange in patients with acute lung injury. Chest 1998;114(1):223-228.
31. Jolliet P, Bulpa P, Ritz M, Ricou B, Lopez J, Chevrolet JC. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome. Crit Care Med 1997;25(5):786-794.
32. Morelli A, Teboul JL, Maggiore SM, Vieillard-Baron A, Rocco M, Conti G, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006;34(9):2287-2293.
33. Bosma KJ, Taneja R, Lewis JF. Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches. Drugs 2010;70(10):1255-1282.
34. Papazian L, Bregeon F, Gaillat F, Thirion X, Roch A, Cortes E, et al. Inhaled NO and almitrine bismesylate in patients with acute respiratory distress syndrome: Effect of noradrenalin. Eur Respir J 1999; 14(6):1283-1289.
35. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 2006; 21(3):119-143.
36. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009;37(5):1574-1579.
37. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, et al. Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med 2009;179(3):220-227.
38. Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest 2011; 139(2):289-295.
39. Kor DJ, Erlich J, Gong MN, Malinchoc M, Carter RE, Gajic O, et al. Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med 2011;39(11):2393-2400.
40. Cuesta JM, Singer M. The stress response and critical illness: a review. Crit Care Med 2012;40(12):3283-3289.
41. Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and therapeutics of bronchodilators. Pharmacol Rev 2012;64(3):450-504.
42. Scheinin M, Koulu M, Laurikainen E, Allonen H. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol 1987;24(5):645-653.
43. Stratakos G, Kalomenidis J, Routsi C, Papiris S, Roussos C. Transient lactic acidosis as a side effect of inhaled salbutamol. Chest 2002;122(1):385-386.
44. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53(11):1119-1129.
45. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526-2533.
46. Burns KE, Adhikari NK, Keenan SP, Meade MO. Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev 2010(8): CD004127.